Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease

Published:2015 Issue:3 Volume:21 Page:194-200
ISSN:1341-1098
Container-title:Annals of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:ATCS

Author:

Yoshida Yukihiro¹,Kage Hidenori²,Murakawa Tomohiro¹,Sato Yasunori³,Ota Satoshi⁴⁵,Fukayama Masashi⁵,Nakajima Jun¹

Affiliation:

1. Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan

2. Department of Respiratory Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan

3. Clinical Research Center, Chiba University Hospital, Chiba, Chiba, Japan

4. Department of Pathology, Chiba University Hospital, Chiba, Chiba, Japan

5. Department of Pathology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan

Publisher

Editorial Committee of Annals of Thoracic and Cardiovascular Surgery

Subject

Gastroenterology,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

https://www.jstage.jst.go.jp/article/atcs/21/3/21_oa.14-00200/_pdf

Reference29 articles.

1. 1) Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.

2. 2) The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Online: http://www.goldcopd.org/

3. 3) Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34: 17-41.

4. 4) Brunelli A, Kim AW, Berger KI, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: e166S-90S.

5. 5) Wright CD, Gaissert HA, Grab JD, et al. Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model. Ann Thorac Surg 2008; 85: 1857-65; discussion 1865.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled medications for chronic obstructive pulmonary disease predict surgical complications and survival in stage I non-small cell lung cancer;Journal of Thoracic Disease;2023-12

2. The Prognostic Role of Chronic Obstructive Pulmonary Disease for Lung Cancer After Pulmonary Resection;Journal of Surgical Research;2022-07

3. Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2022

4. Definition and assessment of high risk in patients considered for lobectomy for stage I non–small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document;The Journal of Thoracic and Cardiovascular Surgery;2021-12

5. Prognostic and functional impact of perioperative LAMA/LABA inhaled therapy in patients with lung cancer and chronic obstructive pulmonary disease;BMC Pulmonary Medicine;2021-05-21